These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21729605)

  • 1. [Expression of vWF73 and VWF114 fragments of von Willebrand factor A2 domain and their utilization in detecting ADAMTS13 activity].
    Zhang JY; Ma ZN; Dong NZ; Hu LP; Su J; Wang ZY; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):337-41. PubMed ID: 21729605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).
    Hommais A; Rayes J; Houllier A; Obert B; Legendre P; Veyradier A; Girma JP; Ribba AS
    Thromb Haemost; 2007 Sep; 98(3):593-9. PubMed ID: 17849048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement.
    Joly B; Stepanian A; Hajage D; Thouzeau S; Capdenat S; Coppo P; Veyradier A
    Thromb Res; 2014 Nov; 134(5):1074-80. PubMed ID: 25262108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.
    Mancini I; Valsecchi C; Lotta LA; Deforche L; Pontiggia S; Bajetta M; Palla R; Vanhoorelbeke K; Peyvandi F
    Thromb Haemost; 2014 Aug; 112(2):297-303. PubMed ID: 24740645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity.
    Kato S; Matsumoto M; Matsuyama T; Isonishi A; Hiura H; Fujimura Y
    Transfusion; 2006 Aug; 46(8):1444-52. PubMed ID: 16934083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations.
    Zhou W; Tsai HM
    Thromb Haemost; 2004 Apr; 91(4):806-11. PubMed ID: 15045144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of a novel ADAMTS13 activity assay for diagnosis of TMA and criteria for judgment of platelet transfusion].
    Hiura H
    Rinsho Byori; 2007 Jan; 55(1):69-75. PubMed ID: 17319494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13.
    Kokame K; Matsumoto M; Fujimura Y; Miyata T
    Blood; 2004 Jan; 103(2):607-12. PubMed ID: 14512308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A2 domain of human von Willebrand factor expressed in E. coli and its biological activity].
    Su J; Bai X; Gao WQ; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1090-3. PubMed ID: 16403287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor.
    Pruss CM; Notley CR; Hegadorn CA; O'Brien LA; Lillicrap D
    Br J Haematol; 2008 Nov; 143(4):552-8. PubMed ID: 18986390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura.
    Deforche L; Tersteeg C; Roose E; Vandenbulcke A; Vandeputte N; Pareyn I; De Cock E; Rottensteiner H; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    PLoS One; 2016; 11(8):e0160388. PubMed ID: 27479501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli-derived von Willebrand factor-A2 domain fluorescence/Förster resonance energy transfer proteins that quantify ADAMTS13 activity.
    Dayananda KM; Gogia S; Neelamegham S
    Anal Biochem; 2011 Mar; 410(2):206-13. PubMed ID: 21146487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.
    Shelat SG; Ai J; Zheng XL
    Semin Thromb Hemost; 2005 Dec; 31(6):659-72. PubMed ID: 16388417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a disintegrin-like and metalloprotease with thrombospondin type 1 repeat motifs 13 (ADAMTS13) activity enzyme-linked immunosorbent assay for measuring plasma ADAMTS13 activity in dogs.
    Maruyama H; Kaneko M; Otake T; Kano R; Yamaya Y; Watari T; Hasegawa A; Kamata H
    J Vet Diagn Invest; 2014 Mar; 26(2):226-31. PubMed ID: 24583948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and clinical application of a new method for detecting ADAMTS13 activity.
    Wang AY; Dong NZ; Ma ZN; Zhang JY; Su J; Ruan CG
    Chin Med J (Engl); 2010 Jul; 123(14):1859-63. PubMed ID: 20819568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.
    Pillai VG; Bao J; Zander CB; McDaniel JK; Chetty PS; Seeholzer SH; Bdeir K; Cines DB; Zheng XL
    Blood; 2016 Jul; 128(1):110-9. PubMed ID: 27207796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of von Willebrand factor pro-peptide and ADAMTS13 in diagnosis of thrombotic thrombocytopenic purpura].
    Ji J; Liu T; Meng WT; Lu ZP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):807-10. PubMed ID: 22332547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
    Starke R; Machin S; Scully M; Purdy G; Mackie I
    Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.
    Manea M; Kristoffersson A; Tsai HM; Zhou W; Winqvist I; Oldaeus G; Billström R; Björk P; Holmberg L; Karpman D
    Eur J Pediatr; 2007 Mar; 166(3):249-57. PubMed ID: 17187257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.